1.50182

Hibar^® RT HPLC Columns for customized packing

L × I.D. 250 mm × 4 mm, please select HPLC sorbent for Column filling

• Sinonimo/i: TM=["Hibar"] RT column for customized packing
• Codice UNSPSC: 41115709
• NACRES: SB.52

Proprietà

• Nome del prodotto: Hibar^® 250-4, suitable for HPLC
• Parametri: 400 bar pressure
• Livello qualitativo: 100
• tecniche: HPLC: suitable
• Lungh. × diam. int. colonna: 25 cm × 4 mm
• Tecnica di separazione: supercritical fluid (SFC)
• Temperatura di conservazione: no temp limit

Descrizione

Descrizione generale

HPLC column, customized packing, please specify packing material

Applicazioni

• High performance liquid chromatographic assay of amlodipine, valsartan and hydrochlorothiazide simultaneously and its application to pharmaceuticals, urine and plasma analysis: This study highlights the utilization of high-performance liquid chromatography (HPLC) for analyzing complex mixtures in pharmaceuticals and biological samples, demonstrating the sophisticated capabilities of devices like Hibar 250-4 in handling and analyzing precision samples in high-stakes environments such as pharmaceutical quality control and medical diagnostics (Shaikh JSA, Raut S, Abdul A, Pathan MAAK, 2020).
• Identification and characterization of stress degradation products of sumatriptan succinate by using LC/Q-TOF-ESI-MS/MS and NMR: The research involves advanced chromatographic techniques which could be relevant for applications using Hibar 250-4 pumps in rigorous testing environments to identify and quantify degradation products, ensuring drug safety and efficacy (Udutha S, Shankar G, Borkar RM, et al., 2018).
• Accumulation and trends in distribution of three triterpenoids in various parts of Achyranthes coynei determined using RP-UFLC analysis: This publication shows the application of ultra-fast liquid chromatography, a field where Hibar 250-4′s precision dosing could be pivotal, in the pharmacognostic study of plant materials, aiding in the rapid and effective separation of complex natural products (Upadhya V, Ankad GM, Pai SR, et al., 2014).
• Development and validation of a HPLC-PDA bioanalytical method for the simultaneous estimation of Aliskiren and Amlodipine in human plasma: This study presents a validated method for the simultaneous estimation of two pharmaceutical agents in plasma, using HPLC systems like Hibar 250-4 to achieve high precision and accuracy required for therapeutic drug monitoring and pharmacokinetic studies (Mannemala SS, Nagarajan JS, 2015).

Note legali

Hibar is a registered trademark of Merck KGaA, Darmstadt, Germany